MedTrace Logo

A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers

NCT01068223 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-09-04

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of JNJ-39758979 compared to placebo on histamine induced itch in healthy male volunteers.

Conditions

  • Histamine Induced Itch

Interventions

DRUG

A:JNJ-39758979/Placebo #1

Single oral dose of JNJ-39758979 600 mg and Placebo

DRUG

C:Cetirizine/JNJ-39758979 Matching Placebo

JNJ-39758979 Matching Placebo and Placebo #2

DRUG

B: JNJ-39758979 Matching Placebo /Placebo #2

A single dose of 2 different Placebos

Sponsors & Collaborators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Completion
2010-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01068223 on ClinicalTrials.gov